Mitsui Global Investment — Full Portfolio

Rallybio is a clinical-stage biotech company developing therapies for people with severe and rare diseases, with a pipeline focused on complement dysregulation and hematology.

BiotechHealthtechNew Haven, US

SUStephen Uden(Founder)inMWMartin W. Mackay(Chairman of the Board of Directors)inJon(Chief Financial Officer)

Co-investors5A5AM VenturesCACanaan PartnersCOConnecticut InnovationsF-F-Prime CapitalSOSolasta VenturesPIPivotal Life Sciences

Valens develops high-performance connectivity chipsets that are embedded in devices to support digital and connectivity experiences.

Deep TechHardwareMobility & TransportationSemiconductors

Co-investors1010DAMAmiti VenturesAVAviv Venture CapitalF4F4 VenturesMAMagenta Venture Partners

Biotech developing small-molecule therapies for respiratory, inflammatory and autoimmune diseases, acquired by Boehringer Ingelheim.

BiotechSan Mateo, US

Peter McWilliams(Executive Officer, Director)KBKevin Bacon(Executive Officer, Director)in

BoardFred Middleton(Director)MMMasaji Matsuoka(Director)in

Biotechnology company developing blood-brain-barrier-penetrating recombinant protein therapies for CNS disorders; acquired by JCR Pharmaceuticals in 2020.

RBRuben Boado(Founder)in

Israeli fabless semiconductor company making vehicle-to-everything (V2X) communication chipsets for connected and autonomous vehicles.

Co-investorsAMAmiti VenturesFRFraser McCombs CapitalMAMagenta Venture PartnersMAManiv MobilitySASamsung Catalyst Fund

GoSecure is a Managed Detection and Response (MDR) cybersecurity provider based in Montreal and San Diego.

San Diego, US

Co-investorsEAEastward Capital PartnersRARazor's Edge VenturesYAYaletown PartnersEDEdge

Mahzi develops therapies for patients with under-diagnosed and under-served rare genetic neurodevelopmental disorders, working with patient and family groups, academic researchers, and industry partners.

BiotechHealthtechSouth San Francisco, US

YWYael Weiss(Executive Officer, Director)in

BoardCSCamille Samuels(Director)inMSMarten Steen(Director)inSSShalini Sharp(Director)inStephen Farr(Director)

Co-investorsDRDroia VenturesHEHealthCapVEVenrockVEVenrock Associates

Davis, California developer of biological crop protection, plant health and waterway treatment products, formerly NASDAQ: MBII.

AgTechDavis, US

PGPamela G. Marrone(Executive Officer, Director)James B. Boyd(Executive Officer)Linda V. Moore(Executive Officer)inDGDon Glidewell(Executive Officer)inJulie I Morris(Executive Officer)inCHChris Hildreth(Executive Officer)in

Co-investorsBABand of Angels

MC10 developed conformal BioStamp wearable sensors and clinical analytics for physiological data capture in clinical research.

BiotechDigital HealthHealthtechMedical DevicesLexington, US

John Rogers(Director)David Icke(Executive Officer, Director)Alice Sansone(Executive Officer)Steven N. Tannenbaum(Executive Officer)Scott D. Pomerantz(Executive Officer, Director)

BoardMSMarc Singer(Director)in

Co-investorsBRBraemar Energy VenturesOUOUP (Osage University Partners)WIWindham Capital PartnersABAberdare VenturesNONorth Bridge Venture Partners

Neura Health provides telemedicine video visits with board-certified neurologists for conditions including migraine, epilepsy, sleep disorders, tremor, concussion, and stroke.

Digital HealthHealthtechNew York, US

SMSameer Madan(Founder)inEBElizabeth Burstein(Founder)in

Co-investorsCOCorrelation VenturesE1E12 Venture Capital, LlcKOKoch Disruptive TechnologiesNENext Play VenturesANANDHealth ACTIVATE

OpenX is a supply-side platform (SSP) for digital advertising that uses AI, data leadership, and proprietary identity technology to manage ad inventory and targeting.

AdTechAI & Machine LearningNot specified on page, US

DRDAMON REEVE(Director)inTCTIM CADOGAN(Executive Officer, Director)in

BoardNMNINO MARAKOVIC(Director)inANDREW Scott BRACCIA(Director)BDBERNARD DALLE(Director)inJON MILLER(Director)

Co-investorsCHChartline Capital PartnersDADag VenturesINIndex VenturesPRPresidio VenturesSASapphire VenturesSESecond Alpha Partners+2 more

Pica8 develops PICOS, a Linux-based open network operating system, and the AmpCon controller for white box enterprise networks.

Palo Alto, US

Chunyi (James) Liao(Executive Officer, Director)

BoardTCTerry Chen(Director)inChen-Wen Tarn(Director)Mike Splinter(Director)

Co-investorsVAVantagePoint Capital Partners

Proterra designs and manufactures zero-emission battery systems for commercial vehicles.

CleantechHardwareMobility & TransportationGreenville, US

RPRyan Popple(Executive Officer, Director)Eric McCarthy(Executive Officer)C. W. Plummer, Jr.(Executive Officer)Dave Rich(Executive Officer)

BoardRob Johnson(Director)Michael Smith(Director)

Co-investorsBMBMW i VenturesCOConductive VenturesCOConstellation Technology VenturesENEnergy Impact PartnersEVEvolution VC PartnersOBObvious Ventures+6 more

QD Laser develops, manufactures, and sells high-efficiency semiconductor lasers for telecommunications and industrial use, as well as visual-information devices.

Deep TechHardwareMedical DevicesSemiconductorsYokohama, JP

MSMitsuru Sugawara(Founder)in菅原 充(Founder & Chief Technology Advisor)大久保 潔(President & Representative Director)

Co-investorsBEBeyond Next VenturesMIMIRAI SOUZOUOIOita Venture CapitalSMSMBC Venture CapitalUNUntroD CapitalUTUTokyo Innovation Platform Co. Ltd.+1 more

QurAlis develops precision therapies for amyotrophic lateral sclerosis (ALS) and related neurodegenerative diseases by targeting specific disease-causing genetic drivers and molecular mechanisms.

BiotechDeep TechMedical DevicesCambridge, US

KEKevin Eggan(Co-founder)inRoet(Co-founder)Woolf(Co-founder)KRKasper Roet(Director, Executive Officer, Promoter)inSVShafique Virani(Executive Officer)inJBJason Brown(Mr. Brown is the Chief Financial Officer of the Issuer.)in

Co-investorsDRDroia VenturesMCMC Healthcare VenturesMIMission BiocapitalSASanofi VenturesSVSV Health InvestorsAMAmgen Ventures+7 more

Reunion Neuroscience is a clinical-stage biopharmaceutical company developing serotonergic psychedelic therapies for mental health conditions such as postpartum depression, adjustment disorder, and generalized anxiety disorder.

BiotechDigital HealthMental HealthMorristown, US

Sahil V. Kirpekar(President and CEO)inGregory Mayes(Executive Officer, Director)ELEllen Lubman(Director)MPMark Pollack(Executive Officer)inNBNathan Bryson(Executive Officer)inMTMark Theeuwes(Executive Officer)in

Co-investorsFEFemHealth VenturesMPMPM BioImpactNONovo Holdings

Rhino builds a system of record for enterprise business logic, rules, and decisions that are typically scattered across legacy systems and processes.

AI & Machine LearningData & InfrastructureDeveloper ToolsEnterprise Software

Co-investorsKOKoch Disruptive TechnologiesLILionBirdALAlleyCorpGAGaingelsQIQiming Venture Partners USATITiger Global Management+1 more

Rhino Federated Computing provides enterprise software infrastructure enabling organizations to run AI, analytics, and data workflows across distributed data environments while preserving privacy and security.

AI & Machine LearningData & InfrastructureEnterprise SoftwareBoston, US

DIDr. Ittai DayaninYBYuval Baror(Founder)in

Co-investorsALAlleyCorpE1E12 Venture Capital, LlcFUFusionLILionBirdALAlley Robotics VenturesVOVolution Ventures

Monmouth Junction, US

DCDavid C. Aldous(Executive Officer, Director)in

BoardWilliam Wiberg(Director)Jamie Kiggen(Director)DCDaniel Carter(Director)inMichael Zak(Director)David J. Tippeconnic(Director)

Co-investorsARAramco VenturesSASaudi Aramco Energy VenturesTHThe Blackstone Group

JS Communications provides network integration services, infrastructure solutions, and security technologies for enterprise IT systems.

Cloud ComputingCybersecurityData & InfrastructureEnterprise SoftwareIoTTokyo, JP

William Kish(Executive Officer, Director)Victor Shtrom(Executive Officer)Selina Lo(Executive Officer, Director)James Hennessy(Executive Officer)愛須 康之(代表取締役会長 (Representative Director & Chairman))渡邉 辰夫(代表取締役社長 (Representative Director & President))

Co-investorsMOMobile Internet Capital, Inc.WIWingSESequoia Capital

Sirrus develops chemical building blocks based on patented methylene malonate monomers and oligomeric crosslinkers that polymerize anionically at ambient temperatures.

Advanced ManufacturingCleantechDeep TechNew MaterialsLoveland, US

BMBernard Malofsky(Executive Officer)inJUJeff Uhrig(President, Chief Executive Officer, Secretary and Treasurer)inRobert Smith(Executive Officer)Adam Malofsky(Director)

BoardWLWilliam Lese(Director)inDoug Cameron(Director)

Co-investorsBRBraemar Energy VenturesCICincyTechARArsenal

Spire operates a constellation of nanosatellites that collect granular Earth and environmental data from orbit, providing analytics for climate, logistics, and community protection.

Climate TechData & InfrastructureLogistics & Supply ChainSpace TechVienna, Virginia, US

PPPeter Platzer(Founder)inJCJeroen Cappaert(Founder)inJSJoel Spark(Founder)inTCTheresa Condor(Executive Officer, Director)inCelia Perez Pelaz(Executive Officer)TKThomas Krywe(Executive Officer)in

Co-investorsBEBessemer Venture PartnersEVEvolution VC PartnersEXExpon CapitalFRFresco CapitalGPGPO FundGRGrishin Robotics+9 more

Stately Bio develops stem cell-derived regenerative and cell therapies using a machine learning platform that measures cell identity, behavior, and maturation directly from live-cell, label-free imaging.

AI & Machine LearningBiotechMedical Devices

Frank Li(Founder & CEO)Christian Elabd, PhD(Head of Biology)

Co-investorsAIAIX VenturesFOFoothill VenturesAXAxial VCBOBoxOne VenturesCACaffeinated CapitalDIDimension Capital+1 more

Svante builds filters and modular rotary contactor machines that capture and remove CO2 from industrial emissions and directly from the air.

CleantechClimate TechDeep TechEnergyNew MaterialsBurnaby, CA

Matthew Stevenson(Executive Officer)inCLClaude Letourneau(President & CEO)

BoardMarc Van Den Berg(Director)Roger Strauch(Director)inDamien Vacherot(Director)Laura Boudreau(Director)

Co-investorsCHChrysalixTHThe Roda GroupCHChevron Technology VenturesMIMitsui & CoTETemasekBABay Bridge Ventures Climate+3 more

Tacit Therapeutics develops RNA-based gene therapy approaches by redirecting cellular splicing processes to repair mutated genes.

BiotechDeep TechHealthtechSan Francisco, US

Co-investorsEIEisai Innovation, Inc.KDKdT Ventures

Therini Bio is a biotechnology company developing fibrin-targeting therapeutics to treat neurological and ophthalmological diseases, leveraging scientific discoveries in neurovascular and neuroimmune mechanisms of disease.

BiotechDigital HealthHealthtechMedical DevicesSacramento, US

KAKaterina Akassoglou(Scientific Founder, Director of the Center for Neurovascular Brain Immunology and Professor of Neurology at UCSF and Gladstone Institutes)inKAKaterina Akassoglou, PhD(Scientific Founder)LSLeslie Schulze(Executive Officer)TNTara Nickerson(Executive Officer, Director)in

BoardODOlga Danilchanka(Director)inLaia Crespo-Martin(Director)

Co-investorsMRMRL Ventures FundSASanofi VenturesSVSV Health InvestorsANAngelini VenturesAPApollo Health VenturesDEDementia Discovery Fund+2 more

Waypoint Bio uses artificial intelligence, computer vision, and pooled screening to conduct deep phenotyping across thousands of cell therapy designs, enabling the discovery and optimization of superior cell therapy candidates for development.

AI & Machine LearningBiotechDeep Tech

Xinchen Wang, Ph.D.(Co-founder & CEO)DPDavid Phizicky, Ph.D.(Co-founder & CSO)Xinchen Wang(Founder)in

Co-investorsAMAmplify PartnersFIFifty YearsHUHummingbird VenturesMBMBX CapitalRERecode VenturesAMAmplify Partners CV+2 more